Dr. Avni M. Desai, MD

Dr. Desai practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Desai's NPI, 1104010149, was assigned on September 4, 2007. Dr. Desai graduated from Tufts University School Of Medicine in 2004. Dr. Desai's Virginia license number on file is 0101242314.

Dr. Desai's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Desai's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Desai to 2 more group practices and clinics, 1 home health agency, 1 hospice and 1 medical group, each named with a free account. Dr. Desai's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Desai practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Desai's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Desai is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Desai's licenses on file in 6 states: Virginia, Florida, New York, New Jersey, District of Columbia and Maryland.

Dmand AI lists chronic anemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and prostate cancer among the conditions Dr. Desai treats.

CMS data shows 1,053 Medicare services from Dr. Desai across 5 procedure codes in 2024, for 305 Medicare patients. Medicare paid $100,188 for them.

CMS counts 305 Medicare patients who saw Dr. Desai in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Desai's median patient age at 73, with 49% women.

In 2024, Dr. Desai wrote 1,160 Medicare Part D claims for 201 patients. 77% of them were for generic drugs. CMS names the drug for 946 of them, across 24 drugs with 11 or more claims each, at $442,567 in total drug cost. In 2023, CMS named 768 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Desai for performance year 2024, reported as part of a group. Dr. Desai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Desai as offering telehealth.

Dmand AI links 14 papers to Dr. Desai, published from 2014 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Stomach Neoplasms and Adenocarcinoma. Dr. Desai has published most often in N Engl J Med. Dr. Desai's most frequent co-authors are Yelena Y. Janjigian, MD, Geoffrey Yuyat Ku, MD and David H. Ilson, MD.

CMS Open Payments shows 5 general payments to Dr. Desai from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. AstraZeneca Pharmaceuticals LP paid the most, $95.

Dr. Desai graduated from Tufts University School Of Medicine in 2004.

Dr. Desai is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.